Generic drug makerLabelled by claude-haiku-5.5 from the firm's FDA names. It is not an FDA field. in TürkiyeLabelled by claude-haiku-5.5 from the firm's FDA names. It is not an FDA field.. FDA records under 2 spellings of its name, each linked to the record.
As of Nov 13, 2026, FDA's public records list Deva Holding A.S. and its 1 subsidiaries with 13 drug applications and 6 drug recalls. The most recent is a drug recall dated Jul 16, 2019: Temozolomide Capsules, 180 mg, packaged in a) 5-count bottle (NDC 67877-541-07), b) 14-c….
Drug approvals, 510(k) clearances, recalls and letters, 2017 to 2026 to date, Deva Holding A.S. and its 1 subsidiaries
A hatched bar is a year that is not over, so its count covers only part of the year.
| Date | Record | Source |
|---|---|---|
| Jul 16, 2019 | Temozolomide Capsules, 180 mg, packaged in a) 5-count bottle (NDC 67877-541-07), b) 14-count bottle (NDC 67877-541-14), Rx only, ManufactureClass II · CGMP Deviations: product was manufactured that did not prevent possible cross contamination with beta lactam products. | Drug recalls |
| Jul 16, 2019 | Temozolomide Capsules, 100 mg, packaged in a) 5-count bottle (NDC 67877-539-07), b) 14-count bottle (NDC 67877-539-14), Rx only, ManufactureClass II · CGMP Deviations: product was manufactured that did not prevent possible cross contamination with beta lactam products. | Drug recalls |
| Jul 16, 2019 | Temozolomide Capsules, 20 mg, packaged in a) 5-count bottle (NDC 67877-538-07), b) 14-count bottle (NDC 67877-538-14), Rx only, ManufacturedClass II · CGMP Deviations: product was manufactured that did not prevent possible cross contamination with beta lactam products. | Drug recalls |
| Jul 16, 2019 | Temozolomide Capsules, 250 mg, 5-count bottle, Rx only, Manufactured by: Deva Holding A.S., 1 Merkez Mahallesi, Istanbul, Turkey 34303, DistClass II · CGMP Deviations: product was manufactured that did not prevent possible cross contamination with beta lactam products. | Drug recalls |
| Jul 16, 2019 | Temozolomide Capsules, 140 mg, packaged in a) 5-count bottle (NDC 67877-540-07), b) 14-count bottle (NDC 67877-540-14), Rx only, ManufactureClass II · CGMP Deviations: product was manufactured that did not prevent possible cross contamination with beta lactam products. | Drug recalls |
| Jul 16, 2019 | Temozolomide Capsules, 5 mg, packaged in a) 5-count bottle (NDC 67877-537-07), b) 14-count bottle (NDC 67877-537-14), Rx only, Manufactured Class II · CGMP Deviations: product was manufactured that did not prevent possible cross contamination with beta lactam products. | Drug recalls |
Spellings are joined only when they reduce to the same name, or a reviewed source names the same company. Sharing an FDA establishment number (FEI) is not enough: contract sites make products for many firms. Facts marked AI were labelled by a language model from the firm's FDA names; everything else comes from FDA or Wikidata. How this page is built
